Lisata Therapeutics Inc (LSTA)
2.90
+0.10
(+3.48%)
USD |
NASDAQ |
May 08, 09:49
Lisata Therapeutics Max Drawdown (5Y): 96.73% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.73% |
March 31, 2024 | 96.73% |
February 29, 2024 | 96.73% |
January 31, 2024 | 96.73% |
December 31, 2023 | 96.73% |
November 30, 2023 | 96.73% |
October 31, 2023 | 96.73% |
September 30, 2023 | 96.73% |
August 31, 2023 | 96.73% |
July 31, 2023 | 96.73% |
June 30, 2023 | 96.73% |
May 31, 2023 | 96.73% |
April 30, 2023 | 96.73% |
March 31, 2023 | 96.73% |
February 28, 2023 | 96.73% |
January 31, 2023 | 96.73% |
December 31, 2022 | 96.73% |
November 30, 2022 | 96.73% |
October 31, 2022 | 96.73% |
September 30, 2022 | 96.73% |
August 31, 2022 | 96.95% |
July 31, 2022 | 96.95% |
June 30, 2022 | 96.95% |
May 31, 2022 | 96.95% |
April 30, 2022 | 96.95% |
Date | Value |
---|---|
March 31, 2022 | 96.95% |
February 28, 2022 | 96.95% |
January 31, 2022 | 96.95% |
December 31, 2021 | 96.95% |
November 30, 2021 | 96.95% |
October 31, 2021 | 96.95% |
September 30, 2021 | 96.95% |
August 31, 2021 | 96.95% |
July 31, 2021 | 96.95% |
June 30, 2021 | 96.95% |
May 31, 2021 | 96.95% |
April 30, 2021 | 96.95% |
March 31, 2021 | 96.95% |
February 28, 2021 | 96.95% |
January 31, 2021 | 96.95% |
December 31, 2020 | 96.95% |
November 30, 2020 | 97.43% |
October 31, 2020 | 97.43% |
September 30, 2020 | 97.43% |
August 31, 2020 | 97.43% |
July 31, 2020 | 97.43% |
June 30, 2020 | 97.43% |
May 31, 2020 | 97.43% |
April 30, 2020 | 97.43% |
March 31, 2020 | 97.43% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.73%
Minimum
Sep 2022
97.43%
Maximum
May 2019
97.03%
Average
96.95%
Median
Dec 2020
Max Drawdown (5Y) Benchmarks
Becton Dickinson & Co | 29.62% |
Edwards Lifesciences Corp | 52.78% |
AIM ImmunoTech Inc | 99.76% |
Protalix BioTherapeutics Inc | 94.35% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 38.06 |
Beta (5Y) | -3.796 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 619.8% |
Historical Sharpe Ratio (5Y) | -0.0068 |
Historical Sortino (5Y) | -0.1173 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.39% |